Molecular and phenotypic detection technologies

Hospitals are increasingly encountering unpredictable resistance patterns clinically while being faced with the need to minimise broad-spectrum antibiotic use to prevent and reduce antimicrobial resistance. For patients with sepsis, time to effective and optimised therapy is critical. Accelerate Diagnostics has created breakthrough diagnostic solutions by developing technologies that address the needs of clinicians and the laboratory.

The company’s fully automated ID/AST system Accelerate Pheno and direct from positive blood culture kit Accelerate PhenoTest BC utilise proprietary molecular and phenotypic detection technologies that have been demonstrated to reduce substantially the time to definitive, actionable antimicrobial susceptibility and MIC results by one to two days, compared with conventional methods.


Other news

Upcoming Events

Focus 2019

SEC Glasgow
1-3 May 2019

Respiratory Microbiology - A Day of Inspiration

Royal Air Force Museum, Hendon
16 May 2019

Clinical and Laboratory Haemostasis 2019

The Atrium Conference Centre, Sheffield Hallam University
5-6 June 2019

The Oxford Haematology in Obstetrics Postgraduate Course

St Edmund Hall, Queen's Lane, Oxford OX1 4AR
9-11 September 2019

IBMS Biomedical Science Congress

ICC, Birmingham
22-25 September 2019

Latest Issue

Pathology In Practice

Pathology In Practice

Apr 2019

Reducing exposure to antimicrobial agents

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.